Aurora Cannabis Inc. (NASDAQ:ACB) Receives Consensus Rating of “Moderate Buy” from Analysts

Aurora Cannabis Inc. (NASDAQ:ACB) has been given a consensus rating of “Moderate Buy” by the five research firms that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, one has assigned a buy recommendation and two have assigned a strong buy recommendation to the company.

A number of analysts recently commented on the company. Zacks Research raised Aurora Cannabis from a “strong sell” rating to a “hold” rating in a research note on Monday, October 6th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Aurora Cannabis in a research report on Wednesday, October 8th.

Aurora Cannabis Trading Up 3.2%

NASDAQ:ACB traded up $0.13 during mid-day trading on Friday, reaching $4.21. 1,020,931 shares of the company’s stock traded hands, compared to its average volume of 1,031,000. The company has a 50 day moving average price of $5.07 and a 200-day moving average price of $4.99. The firm has a market capitalization of $238.71 million, a price-to-earnings ratio of -6.10 and a beta of 1.71. The company has a debt-to-equity ratio of 0.06, a current ratio of 3.41 and a quick ratio of 1.63. Aurora Cannabis has a 12-month low of $3.42 and a 12-month high of $6.91.

Aurora Cannabis (NASDAQ:ACB) last released its quarterly earnings data on Wednesday, November 5th. The company reported $0.09 earnings per share for the quarter, topping the consensus estimate of $0.03 by $0.06. The business had revenue of $64.88 million during the quarter, compared to analysts’ expectations of $86.45 million. Aurora Cannabis had a negative return on equity of 0.58% and a negative net margin of 15.96%. On average, sell-side analysts predict that Aurora Cannabis will post 0.46 earnings per share for the current year.

Institutional Trading of Aurora Cannabis

Large investors have recently bought and sold shares of the company. DKM Wealth Management Inc. purchased a new position in shares of Aurora Cannabis during the 2nd quarter worth approximately $42,000. Northwestern Mutual Wealth Management Co. boosted its position in shares of Aurora Cannabis by 1,808.9% during the third quarter. Northwestern Mutual Wealth Management Co. now owns 10,518 shares of the company’s stock valued at $63,000 after purchasing an additional 9,967 shares in the last quarter. JW Asset Management LLC purchased a new stake in Aurora Cannabis in the first quarter worth $58,000. Wealthcare Advisory Partners LLC bought a new position in Aurora Cannabis in the third quarter worth $81,000. Finally, Headlands Technologies LLC bought a new position in Aurora Cannabis in the second quarter worth $66,000. 47.63% of the stock is owned by institutional investors.

Aurora Cannabis Company Profile

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.